A new euglobulin clot lysis assay for global fibrinolysis. 2003

Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
Department of Pediatrics, Section of Hematology, University of Colorado Health Sciences Center, Denver, CO USA.

Plasma fibrinolytic activity has been measured by the euglobulin clot lysis time (ELT) since the late 1950s. The euglobulin clot lysis assay (ECLA) method has been modified using a computerized kinetic spectrophotometric microtiter plate reader and measures optical density changes of recalcified euglobulin fraction of plasma samples over time. This method has been applied to normal healthy adults, children, pregnant women and newborn infants, which represent physiologic extremes of the ELT. The ECLA method adds measurements of maximum absorbance (Max Abs), area under the curve (AUC) and mean velocity to the standard clot lysis time. The resulting curves are unique to this method and have been analyzed and compared in order to establish normal ranges. Fibrinogen levels, plasminogen activator inhibitor-1 (PAI-1) antigen, PAI-1 activity and thrombin activatable fibrinolytic inhibitor (TAFI) antigen levels were measured in each individual of the four groups. Each protein measured within each study group except TAFI correlated with the lysis time, maximum absorbance and area under the curve. Considering all four groups together, PAI correlates most highly with lysis time, fibrinogen correlates the highest with Max Abs; fibrinogen and PAI-1 antigen have equally high correlations to AUC. Area under the curve is highly correlated with all coagulation parameters measured; the most significant contributor is fibrinogen. These observations are interesting, but at this time, it cannot be said that any of the test parameters are better than lysis time in distinguishing between these normal physiologic states.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses

Related Publications

Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
May 2002, BMC biotechnology,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
June 1975, Clinical biochemistry,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
August 1978, American journal of clinical pathology,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
September 1985, Kanagawa shigaku. The Journal of the Kanagawa Odontological Society,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
November 1980, Scandinavian journal of haematology,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
March 1970, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
August 2021, Thrombosis research,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
May 1953, La Medicina del lavoro,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
March 2015, Biotechnology letters,
Amy A Smith, and Linda J Jacobson, and Brian I Miller, and William E Hathaway, and Marilyn J Manco-Johnson
October 1974, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!